-4 Blood biomarker containing plasma dipeptidyl peptidase-4 for diagnosis of osteoporotic fracture risk

摘要

The present invention relates to a blood biomarker capable of predicting or diagnosing the risk of osteoporotic fracture from the concentration of dipeptidyl peptidase-4.The blood biomarker for the diagnosis of osteoporotic fracture risk including dipeptidyl peptidase-4 of the present invention can predict or diagnose the risk of osteoporotic fracture from the concentration of dipeptidyl peptidase-4 present in plasma and predict the risk of osteoporotic fracture Or diagnostic function of the present invention has remarkably improved action effect as compared with the conventional biomarker.;